News Focus
News Focus
icon url

barnstormer

11/02/25 2:55 PM

#796083 RE: Chiugray #796065

Chiugray, the otc derivatives process described immediately brings to mind the current litigation against Citadel, et al. Not spoofing but certainly leaves the MM's et al the opportunity for abuse.